| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020440871 |
| P356 | DOI | 10.1038/NN.2829 |
| P932 | PMC publication ID | 3780582 |
| P698 | PubMed publication ID | 21572432 |
| P5875 | ResearchGate publication ID | 51126939 |
| P50 | author | Nikolaus R McFarland | Q57004118 |
| Dennis W. Dickson | Q30504740 | ||
| P2093 | author name string | Pritam Das | |
| Todd E Golde | |||
| Wen-Lang Lin | |||
| Paramita Chakrabarty | |||
| Christopher Janus | |||
| Carolina Ceballos-Diaz | |||
| Karen Jansen-West | |||
| Amanda Beccard | |||
| P2860 | cites work | Dopamine transporter SPECT/CT and perfusion brain SPECT imaging in idiopathic basal ganglia calcinosis. | Q45960271 |
| Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. | Q53575010 | ||
| Biochemical evidence of dopaminergic involvement in Fahr's syndrome | Q70713975 | ||
| Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development | Q71543637 | ||
| Does neuroinflammation fan the flame in neurodegenerative diseases? | Q27498993 | ||
| Interferon-γ: an overview of signals, mechanisms and functions | Q28207081 | ||
| Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry | Q34214535 | ||
| Viral parkinsonism. | Q34596492 | ||
| Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition | Q34878224 | ||
| Heredofamilial brain calcinosis syndrome | Q36123911 | ||
| IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice | Q37232963 | ||
| Primary demyelination in transgenic mice expressing interferon-gamma | Q37660490 | ||
| Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease | Q37693988 | ||
| Necrotizing myopathy induced by overexpression of interferon-gamma in transgenic mice | Q41607822 | ||
| Natural killer cell proliferation and circulating cytokines in patients with bilateral basal ganglia calcification | Q42525777 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 694-696 | |
| P577 | publication date | 2011-05-15 | |
| P1433 | published in | Nature Neuroscience | Q1535359 |
| P1476 | title | Interferon-γ induces progressive nigrostriatal degeneration and basal ganglia calcification | |
| P478 | volume | 14 |
| Q36460964 | Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases |
| Q38556918 | Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease |
| Q34795088 | Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain |
| Q21090572 | Differential Co-Expression between α-Synuclein and IFN-γ Signaling Genes across Development and in Parkinson’s Disease |
| Q92528170 | Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders |
| Q64287877 | Hyperactive Innate Immunity Causes Degeneration of Dopamine Neurons upon Altering Activity of Cdk5 |
| Q47382007 | Ifngr1 and Stat1 mediated canonical Ifn-γ signaling drives nigrostriatal degeneration |
| Q37555992 | Inflammatory pre-conditioning restricts the seeded induction of α-synuclein pathology in wild type mice |
| Q40768273 | Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. |
| Q38949649 | Interferon Gamma potentiates the injury caused by MPP(+) on SH-SY5Y cells, which is attenuated by the nitric oxide synthases inhibition |
| Q100558933 | Interferon-γ signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells |
| Q35925767 | Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration |
| Q33625527 | MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration |
| Q35959661 | Microglia-Derived Cytokines/Chemokines Are Involved in the Enhancement of LPS-Induced Loss of Nigrostriatal Dopaminergic Neurons in DJ-1 Knockout Mice |
| Q47649807 | Microglial-induced Müller cell gliosis is attenuated by progesterone in a mouse model of retinitis pigmentosa |
| Q54978235 | Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo. |
| Q45340447 | Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice |
| Q38112215 | Network modeling to identify new mechanisms and therapeutic targets for Parkinson's disease |
| Q38263500 | Neuronal MHC-I expression and its implications in synaptic function, axonal regeneration and Parkinson's and other brain diseases |
| Q38221603 | PDGF, pericytes and the pathogenesis of idiopathic basal ganglia calcification (IBGC). |
| Q37071201 | Parkinson's disease and enhanced inflammatory response. |
| Q37199221 | Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders |
| Q37745148 | Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease. |
| Q38075880 | Review: microglia in protein aggregation disorders: friend or foe? |
| Q41134012 | TGFβ1 inhibits IFNγ-mediated microglia activation and protects mDA neurons from IFNγ-driven neurotoxicity |
| Q38004257 | The immunological challenges of cell transplantation for the treatment of Parkinson's disease. |
| Q35591425 | Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice. |
| Q39124651 | α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies |
Search more.